Cultivating a Partnership with QuantaMatrix for Sepsis Diagnosis “dRAST” in Southeast Asia

Biomed Global & QuantaMatrix On September 5th, QuantaMatrix (317690), a prominent IVD medical device manufacturer, unveiled a significant development in its endeavors by securing an exclusive sales agreement with Biomed Global. This collaboration marks an entrance into the Sepsis treatment in Southeast Asia. A spokesperson from Biomed Global expressed their enthusiasm, stating, “Following extensive deliberations […]

Latent Tuberculosis Infection

SPOT the hidden DANGER of latent TB Active TB vs Latent TB Of the global population, approximately 2 billion people is estimated to be infected with Mycobacterium tuberculosis1. There are two types of tuberculosis (TB) conditions: active tuberculosis (TB) disease and latent TB infection (LTBI). If untreated, approximately 5%–10% of persons with LTBI may progress to […]

Abionic Early Sepsis Detection with Pancreatic Stone Protein (PSP)

Early Sepsis Detection with Pancreatic Stone Protein (PSP) Sepsis Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. Early recognition of sepsis is essential and is a major determinant of the disease’s outcome, according to The WHO and the Surviving Sepsis Campaign. However this has proven to be challenging […]

Unravelling The Complexity Of Tumor Microenvironment With High-Dimensional IHC Analysis Platform

A comprehensive understanding of the tumor microenvironment, including stromal composition, cell-cell and cell-matrix interactions, abnormal physiology, as well as cellular characteristics of heterogenous tumors is the key to elucidating cancer complexities. Understanding the cellular, molecular, and biochemical interactions of tumors within their microenvironment is essential to improving cancer diagnosis and treatment. With multiplexing IHC (mlHC) […]

Review employee support systems and work policies to ensure they are forward thinking

Organizations should constantly improve their talent acquisition and retention framework, review workflows to improve processes, build up financial standing with external stakeholders and adopt automation technology to reduce burden where possible, believes Ng Boon Thiam, Group CEO of Biomed Global. Ng Boon Thiam is the Group CEO of Biomed Global – one of the most […]

A New Platform Technology for Multiplexed Protein Analysis

  Abstract AYOXXA is an NUS spin-off Biotech company. It has developed a novel platform technology that builds on the simple idea to immobilize beads coated with different highly specific antibodies onto a solid-surface array. Detection signals are easily read and mapped by fluorescence microscopy. This setup translates to highly sensitive, precise and accurate multiplexed […]

You are currently visiting Biomed Sinergi from United States.

You can visit one of our website country nearest to you.